PCRX
Pacira BioSciences, Inc.
NASDAQ: PCRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$36.46
+0.00% today
Updated 2026-11-12
Market cap
$1.46B
P/E ratio
39.20
P/S ratio
1.96x
EPS (TTM)
$0.93
Dividend yield
—
52W range
$19 – $37
Volume
1.5M
Pacira BioSciences, Inc. (PCRX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$36.46
12-Month target
$1.09
2030 Target
—
Intrinsic (DCF)
$173.66
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.5B | $0.7B | $0.7B | $0.7B | $0.7B | $0.8B | $0.9B | $1.0B | $1.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 11.07% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 5.08%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.